Abridge valued at $5.3B as it moves to codify billing

Medical AI scribe Abridge has raised $300 million, valuing it at $5.3 billion, per the Wall Street Journal.

Why it matters: It's nearly double the company's February valuation, demonstrating investor confidence that Abridge can expand beyond scribing.